TransCaval Solutions is developing a Closure Device that allows for patients to safely receive the best large catheter alternative access into the heart.
Stage
Prototype Ready
Industry
Medical Devices and Equipment
Location
Miami, FL, USA
Currency
USD
Founded
October 2015
Employees
2
Incorporation Type
C-corp
Company Summary
TCS’s focus is to develop and commercialize a TransCaval Access Closure Device that eliminates bleeding and unpredictability during current TransCaval Access(TCA) procedures. The device will result in safer and more cost effective outcomes in patients that need a catheter based Aortic Valve Replacement(TAVR), Thoracic aneurysm repair(TEVAR) and left sided heart support pump(Impella), but are ineligible for arterial groin access(transfemoral).